FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366603080> ?p ?o ?g. }

• W4366603080 endingPage "1001" @default.
• W4366603080 startingPage "993" @default.
• W4366603080 abstract "This study aimed to optimize the dosing regimens of voriconazole (VRC) for pediatric patients after hematopoietic cell transplantation with different cytochrome P450 (CYP) 2C19 phenotypes and body weights, based on pharmacokinetic (PK)/pharmacodynamic (PD) analysis. The PK parameters of VRC were derived from previous literature. Combined with key factors affecting VRC, patients were categorized into 9 subgroups based on different CYP2C19 phenotypes (poor metabolizer/intermediate metabolizer, normal metabolizer, and rapid metabolizer/ultrarapid metabolizer) and typical body weights (15, 40, and 65 kg). Monte Carlo simulation was used to investigate dosing regimens for different groups. The area under the 24-hour free drug concentration-time curve to the minimum inhibitory concentration (MIC) > 25 was used as the target value for effective treatment. The probability of target achievement and the cumulative fraction of response were determined on the basis of the assumed MICs and MICs distribution frequency of Aspergillus species and Candida species. When the MIC was ≤1 mg/L, 4 mg/kg every 12 hours was sufficient for optimal effects in groups 1-3 and groups 5 and 6; however, 6 mg/kg every 12 hours was required for group 4, and 8 mg/kg every 12 hours was required for groups 7-9. In empirical treatment, lower (2-6 mg/kg every 12 hours) and higher (6-12 mg/kg every 12 hours) dosing regimens were recommended for Candida spp. and Aspergillus spp., respectively. Our findings will assist in selecting appropriate dosing regimens of VRC for pediatric patients after hematopoietic cell transplantation with different CYP2C19 phenotypes and body weights. Clinically, it is better to continuously adjust the dosing on the basis of the therapeutic drug monitoring." @default.
• W4366603080 created "2023-04-23" @default.
• W4366603080 creator A5002790443 @default.
• W4366603080 creator A5004084110 @default.
• W4366603080 creator A5021946286 @default.
• W4366603080 creator A5028065678 @default.
• W4366603080 creator A5033976835 @default.
• W4366603080 date "2023-05-11" @default.
• W4366603080 modified "2023-09-27" @default.
• W4366603080 title "Optimization of Voriconazole Dosing Regimens Against <i>Aspergillus</i> Species and <i>Candida</i> Species in Pediatric Patients After Hematopoietic Cell Transplantation: A Theoretical Study Based on Pharmacokinetic/Pharmacodynamic Analysis" @default.
• W4366603080 cites W1968035018 @default.
• W4366603080 cites W2060781103 @default.
• W4366603080 cites W2106962923 @default.
• W4366603080 cites W2158172729 @default.
• W4366603080 cites W2216117396 @default.
• W4366603080 cites W2339867198 @default.
• W4366603080 cites W2470291098 @default.
• W4366603080 cites W2562778159 @default.
• W4366603080 cites W2619798408 @default.
• W4366603080 cites W2621560236 @default.
• W4366603080 cites W2796455913 @default.
• W4366603080 cites W2800376937 @default.
• W4366603080 cites W2913093012 @default.
• W4366603080 cites W2954084417 @default.
• W4366603080 cites W2976347971 @default.
• W4366603080 cites W2982466502 @default.
• W4366603080 cites W2989765981 @default.
• W4366603080 cites W3013809834 @default.
• W4366603080 cites W3039753571 @default.
• W4366603080 cites W3091544984 @default.
• W4366603080 cites W3092620713 @default.
• W4366603080 cites W3114752537 @default.
• W4366603080 cites W3138654899 @default.
• W4366603080 cites W3149353503 @default.
• W4366603080 cites W3171854987 @default.
• W4366603080 cites W3205540785 @default.
• W4366603080 cites W3207213840 @default.
• W4366603080 cites W3216014487 @default.
• W4366603080 cites W4200623803 @default.
• W4366603080 cites W4224278438 @default.
• W4366603080 cites W4280513280 @default.
• W4366603080 cites W4283706196 @default.
• W4366603080 cites W4283721701 @default.
• W4366603080 cites W4289540026 @default.
• W4366603080 cites W4293758510 @default.
• W4366603080 cites W4297041269 @default.
• W4366603080 cites W4306167919 @default.
• W4366603080 cites W4308804835 @default.
• W4366603080 doi "https://doi.org/10.1002/jcph.2254" @default.
• W4366603080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37083934" @default.
• W4366603080 hasPublicationYear "2023" @default.
• W4366603080 type Work @default.
• W4366603080 citedByCount "0" @default.
• W4366603080 crossrefType "journal-article" @default.
• W4366603080 hasAuthorship W4366603080A5002790443 @default.
• W4366603080 hasAuthorship W4366603080A5004084110 @default.
• W4366603080 hasAuthorship W4366603080A5021946286 @default.
• W4366603080 hasAuthorship W4366603080A5028065678 @default.
• W4366603080 hasAuthorship W4366603080A5033976835 @default.
• W4366603080 hasConcept C111113717 @default.
• W4366603080 hasConcept C112705442 @default.
• W4366603080 hasConcept C126322002 @default.
• W4366603080 hasConcept C140840227 @default.
• W4366603080 hasConcept C16005928 @default.
• W4366603080 hasConcept C2777288759 @default.
• W4366603080 hasConcept C2779548794 @default.
• W4366603080 hasConcept C2780690907 @default.
• W4366603080 hasConcept C2911091166 @default.
• W4366603080 hasConcept C526171541 @default.
• W4366603080 hasConcept C62231903 @default.
• W4366603080 hasConcept C71924100 @default.
• W4366603080 hasConcept C98274493 @default.
• W4366603080 hasConceptScore W4366603080C111113717 @default.
• W4366603080 hasConceptScore W4366603080C112705442 @default.
• W4366603080 hasConceptScore W4366603080C126322002 @default.
• W4366603080 hasConceptScore W4366603080C140840227 @default.
• W4366603080 hasConceptScore W4366603080C16005928 @default.
• W4366603080 hasConceptScore W4366603080C2777288759 @default.
• W4366603080 hasConceptScore W4366603080C2779548794 @default.
• W4366603080 hasConceptScore W4366603080C2780690907 @default.
• W4366603080 hasConceptScore W4366603080C2911091166 @default.
• W4366603080 hasConceptScore W4366603080C526171541 @default.
• W4366603080 hasConceptScore W4366603080C62231903 @default.
• W4366603080 hasConceptScore W4366603080C71924100 @default.
• W4366603080 hasConceptScore W4366603080C98274493 @default.
• W4366603080 hasIssue "9" @default.
• W4366603080 hasLocation W43666030801 @default.
• W4366603080 hasLocation W43666030802 @default.
• W4366603080 hasOpenAccess W4366603080 @default.
• W4366603080 hasPrimaryLocation W43666030801 @default.
• W4366603080 hasRelatedWork W1966443288 @default.
• W4366603080 hasRelatedWork W1985282417 @default.
• W4366603080 hasRelatedWork W2016465981 @default.
• W4366603080 hasRelatedWork W2021319218 @default.
• W4366603080 hasRelatedWork W2914065769 @default.
• W4366603080 hasRelatedWork W2995148693 @default.
• W4366603080 hasRelatedWork W3021369409 @default.
• W4366603080 hasRelatedWork W3174177415 @default.

• next